Form 4: Amgen SVP Derek Miller Reports Stock Disposal to Cover Tax Obligations

Amgen's SVP of Human Resources, Derek Miller, disposed of 152 shares of common stock on May 2, 2024, to cover tax obligations related to vested Restricted Stock Units (RSUs).

Summary

• On May 2, 2024, Derek Miller, SVP of Human Resources at Amgen Inc., reported a transaction involving the disposal of 152 shares of Amgen's common stock.
• The transaction was executed to cover tax obligations related to vested Restricted Stock Units (RSUs).
• Following the transaction, Miller beneficially owns 8,196 shares of Amgen common stock, which includes various RSUs vesting at different dates and Dividend Equivalents (DEs).

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a routine transaction. It doesn't indicate positive or negative sentiment about the company's performance.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies like Amgen. It provides transparency into the transactions of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives, ensuring transparency in stock transactions.
• Companies like Johnson & Johnson, Pfizer, and Merck also regularly disclose similar transactions by their executives.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine disposal of shares by an executive to cover tax obligations.

Key Dates